换一批
换一批Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial.
第一作者：
Weibing,Leng
第一单位：
Colorectal Cancer Center, Sichuan University West China Hospital, No.37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China.;Department of Medical Oncology, Cancer Center, Sichuan University West China Hospital, No.37 Guoxue Lane, Wuhou District, Chengdu, Sichuan, China.
作者：
主题词
人类(Humans);结直肠肿瘤(Colorectal Neoplasms);喹唑啉类(Quinazolines);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);噻吩类(Thiophenes);前瞻性研究(Prospective Studies);苯呋喃类(Benzofurans);复方合剂(Drug Combinations);喃氟啶(Tegafur);氧嗪酸(Oxonic Acid);成年人(Adult);女(雌)性(Female);男(雄)性(Male);中年人(Middle Aged);老年人(Aged);抗药性, 肿瘤(Drug Resistance, Neoplasm);多中心研究(主题)(Multicenter Studies as Topic);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);生活质量(Quality of Life)
DOI
10.1186/s12885-025-13654-7
PMID
40022044
发布时间
2025-03-03
- 浏览0
BMC cancer
376页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
